Registration

TIBER CREEK HEALTH STRATEGIES, INC. for DAIICHI SANKYO, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Matters relating to the pharmaceutical and health care industries. Issues relating to patents.

LobbyistCovered position, as disclosed
JAMES BRYANT HALL New Legislative Director, Senator Bob Graham ; ; Staff Director, Senate Committee on Veterans Affairs

Health Issues HCR

Matters relating to the pharmaceutical and health care industries. Issues relating to patents.

LobbyistCovered position, as disclosed
JAMES BRYANT HALL New Legislative Director, Senator Bob Graham ; ; Staff Director, Senate Committee on Veterans Affairs

Medicare/Medicaid MMM

Matters relating to the pharmaceutical and health care industries. Issues relating to patents.

LobbyistCovered position, as disclosed
JAMES BRYANT HALL New Legislative Director, Senator Bob Graham ; ; Staff Director, Senate Committee on Veterans Affairs

Budget/Appropriations BUD

Matters relating to the pharmaceutical and health care industries. Issues relating to patents.

LobbyistCovered position, as disclosed
JAMES BRYANT HALL New Legislative Director, Senator Bob Graham ; ; Staff Director, Senate Committee on Veterans Affairs

Pharmacy PHA

Matters relating to the pharmaceutical and health care industries. Issues relating to patents.

LobbyistCovered position, as disclosed
JAMES BRYANT HALL New Legislative Director, Senator Bob Graham ; ; Staff Director, Senate Committee on Veterans Affairs

Foreign entities

Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.

EntityCountryPrincipal place of businessOwnershipContribution declared
DAIICHI SANKYO CO., LTD. Japan Japan 100.0% —

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.